By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350



Drug Discovery

Company News
Xencor Provides Updates On Lead Programs And Reviews Bispecific Oncology Partnership; Announces Expansion Of Bispecific Oncology Pipeline At Analyst Day 6/28/2016 8:18:41 AM
Novartis AG (NVS) Taps Xencor's Bispecifics Expertise in $150 Million Immuno-Oncology Deal 6/28/2016 6:36:14 AM
Xencor To Host Analyst Day And Webcast On June 28, 2016 6/15/2016 10:45:29 AM
Xencor Reports Complete Data Results From XmAb7195 Phase 1a Trial Showing Rapid Reduction Of Serum IgE In High IgE Atopic Subjects At American Thoracic Society 2016 International Conference 5/19/2016 6:28:50 AM
Xencor To Present At Upcoming Investor Conferences 5/17/2016 8:06:48 AM
Xencor Reports First Quarter 2016 Financial Results 5/3/2016 7:49:25 AM
Xencor To Host First Quarter 2016 Financial Results Webcast And Conference Call On May 2, 2016 4/25/2016 7:03:39 AM
Xencor Reports Fourth Quarter and Full Year 2015 Financial Results 3/8/2016 6:40:51 AM
Xencor Initiates Two Phase 2 Trials Of Xmab5871 In Igg4-Related Disease And Systemic Lupus Erythematosus 3/8/2016 6:02:17 AM
Xencor To Present At Cowen and Company 36th Annual Health Care Conference 3/2/2016 8:00:44 AM